In the news April 28, 2026
A Critical Moment for Canada: Ensuring World-Leading Access to Innovative Medicines
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
All News
Our news library that includes all press releases and industry related news.
Filter by
In the news October 16, 2025
The Role of Pharma on the Path to New Medicines: A Conversation with IMC by Lung Cancer Canada
Dr. Paul Wheatley-Price chats with IMC President & CEO, Dr. Bettina Hamelin in this episode, covering off what IMC does, the role of […]
In the news March 04, 2024
Leading the way: Empowering women leaders in Canada’s pharma sector
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
In the news February 28, 2024
A year later, none of the $1.5B for rare disease has flowed to patients
Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
In the news February 26, 2024
More than just medicines: Canada’s innovative pharmaceutical industry is contributing to the country’s overall health
This article originally appeared in the Hill Times on February 13, 2024. After a diagnosis, having access to state-of-the-art medicines or treatments […]
In the news October 03, 2023
Patients Deserve Faster Access to Innovative New Medicines
This article originally appeared in the Toronto Star on September 30, 2023. Long wait times for new medicines in Canada, averaging two […]
In the news September 21, 2023
PMPRB report shows increased plan costs, promising pharmaceutical innovation: expert
A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug plan costs but promising pharmaceutical innovation, says Joe Farago, executive director of private payers and investment at Innovative Medicines Canada.
In the news September 05, 2023
Why managing risk more effectively is key for private drug plan sustainability
This article originally appeared in the Benefits and Pensions Monitor on September 5, 2023. ‘If the insurance industry doesn’t upgrade drug insurance […]
In the news August 18, 2023
Fralick: Canada must properly fund its plan to fight antimicrobial resistance
This article originally appeared in the Ottawa Citizen on July 26, 2023 When bacteria and other organisms become resistant to […]
In the news February 28, 2023
The Clock is Ticking for Ottawa to Deliver on Its Rare Disease Strategy
This article originally appeared in Maclean’s print and healthinsights.ca on February 16, 2023 Canada desperately needs a rare disease strategy that’ll enable […]
In the news January 25, 2023
Major hurdles confront Canada’s Biomanufacturing and Life Sciences Strategy
This article originally appeared in Research Money on January 25, 2023. A dwindling workforce, inefficient regulations, and lack of much-needed […]
In the news January 13, 2023
Pharmaceutical Benefits: Ensuring Value for Plan Sponsors
We need to work together to evolve the private market so that it continues to have the value of providing […]
